Efficacy of Trovafloxacin in Treatment of Experimental Staphylococcal or Streptococcal Endocarditis

The efficacy of trovafloxacin against Staphylococcus aureus and viridans group streptococci was investigated in vitro and in an experimental model of endocarditis. The MICs at which trovafloxacin and ciprofloxacin inhibited 90% of clinical isolates of such bacteria (MIC(90)s) were (i) 0.03 and 2 mg/...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Entenza, J. M., Vouillamoz, J., Glauser, M. P., Moreillon, P.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89024/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9869569/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.1.77
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!